Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

Published:2006-02 Issue:2 Volume:130 Page:323-333
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Hanauer Stephen B.,Sandborn William J.,Rutgeerts Paul,Fedorak Richard N.,Lukas Milan,MacIntosh Donald,Panaccione Remo,Wolf Douglas,Pollack Paul

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Tumour necrosis factor and Crohn’s disease;Van Deventer;Gut,1997

2. Tumor necrosis factor;Papadakis;Gastroenterology,2000

3. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease;Murch;Gut,1991

4. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease;Murch;Gut,1993

5. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation;Braegger;Lancet,1992

Cited by 1452 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection;Cureus;2024-09-03

2. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

3. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors;The Korean Journal of Gastroenterology;2024-08-25

4. Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn’s disease;Arab Journal of Gastroenterology;2024-08

5. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3